LDN-193189 (hydrochloride)
目录号 : KCM11414 CAS No. : 1435934-00-1 纯度 : ≥98%
LDN-193189 inhibits SMAD1/5/8 phosphorylation by the bone morphogenetic protein (BMP) type I receptors, which are known as activin receptor-like kinases (ALKs), with an IC value of 4.9 nM. In in vitro kinase assays, it shows specificity for ALK1, 2, 3, and 6 (ICs = 0.8, 0.8, 5.3, and 16.7 nM, respectively) over ALK4 and 5 (ICs = 101 and 350 nM, respectively). LDN-193189 has been used to inhibit BMP type I receptor activity to study the pathogenesis of fibrodysplasia ossificans progressive, a congenital hyperossification disorder, and to examine the role of osteogenesis in prostate tumor metastases in bone.
规格 价格 是否有货 数量
1mg
In-stock
5mg
In-stock
10mg
In-stock
25mg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
分子式
C25H22N6.2HCl
分子量
406.48262
CAS号
1435934-00-1
中文名称
LDN 193189 hydrochloride
储存方式
-20°C
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
在线客服
咨询热线
400-881-9290
关注微信公众号